Medications for Costello Syndrome
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Costello Syndrome.
Found 2 Approved Drugs for Costello Syndrome
Tryngolza
Generic Name
Olezarsen
Tryngolza
Generic Name
Olezarsen
Form: Injection
Method of administration: Subcutaneous
FDA approval date: December 19, 2024
TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). TRYNGOLZA is an APOC-III -directed antisense oligonucleotide (ASO) indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). ( 1 )
Redemplo
Generic Name
Plozasiran
Redemplo
Generic Name
Plozasiran
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 19, 2025
REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). REDEMPLO is an apolipoprotein C-III ( apoC-III )-directed small interfering ribonucleic acid (siRNA) indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). ( 1 )
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances